Document:

ex-10.49

 EXHIBIT 10.49
 

 

 

 LOAN AGREEMENT
 January 11, 2017
 

 Perla Capital Inc. (the “Lender”) of Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Marshall Islands MH96960, advanced CAD$15,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706.  The Lender advanced the funds on January 11, 2017.
 

 The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from January 11, 2017.  The Borrower is liable for repayment of the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.
 

 The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
 

 	 	 	
	 LENDER
	  
	 BORROWER

	 Perla Capital Inc.
	  
	 Cell MedX Corp.

	  
	  
	  

	 Per:
	  
	 Per:

	  
	  
	  

	  
	  
	  

	 /s/ Bernadette Caspillan
	  
	 /s/ Yanika Silina

	 Bernadette Caspillan
	  
	 Yanika Silina, CFO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 PROMISSORY NOTE
 

 	 	
	 Principal Amount: CAD$15,000
	 January 11, 2017

 

 

 FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Perla Capital Inc. (the “Lender”) the sum of $15,000 lawful money of Canada (the “Principal Sum”) together with interest on the Principal Sum from January 11, 2017 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
 

 For the purposes of this promissory note, Interest Rate means six (6) per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
 

 The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.
 

 The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note.
 

 BORROWER
 Cell MedX Corp.
 

 Per:
 

 

 /s/ Yanika Silina
 Yanika Silina, CFOex-10.50

 EXHIBIT 10.50
 

 

 

 LOAN AGREEMENT
 January 13, 2017
 

 Perla Capital Inc. (the “Lender”) of Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Marshall Islands MH96960, advanced USD$25,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706.  The Lender advanced the funds on January 13, 2017.
 

 The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from January 13, 2017.  The Borrower is liable for repayment of the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.
 

 The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
 

 	 	 	
	 LENDER
	  
	 BORROWER

	 Perla Capital Inc.
	  
	 Cell MedX Corp.

	  
	  
	  

	 Per:
	  
	 Per:

	  
	  
	  

	  
	  
	  

	 /s/ Bernadette Caspillan
	  
	 /s/ Yanika Silina

	 Bernadette Caspillan
	  
	 Yanika Silina, CFO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 PROMISSORY NOTE
 

 	 	
	 Principal Amount: USD$25,000
	 January 13, 2017

 

 

 FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Perla Capital Inc. (the “Lender”) the sum of $25,000 lawful money of United States (the “Principal Sum”) together with interest on the Principal Sum from January 13, 2017 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
 

 For the purposes of this promissory note, Interest Rate means six (6) per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
 

 The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.
 

 The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note
 

 BORROWER
 Cell MedX Corp.
 

 Per:
 

 

 /s/ Yanika Silina
 Yanika Silina, CFOex-10.51

 EXHIBIT 10.51
 

 

 

 LOAN AGREEMENT
 February 14, 2017
 

 Perla Capital Inc. (the “Lender”) of Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Marshall Islands MH96960, advanced USD$75,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706.  The Lender advanced the funds on February 14, 2017.
 

 The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from February 14, 2017.  The Borrower is liable for repayment of the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.
 

 The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
 

 	 	 	
	 LENDER
	  
	 BORROWER

	 Perla Capital Inc.
	  
	 Cell MedX Corp.

	  
	  
	  

	 Per:
	  
	 Per:

	  
	  
	  

	  
	  
	  

	 /s/ Bernadette Caspillan
	  
	 /s/ Yanika Silina

	 Bernadette Caspillan
	  
	 Yanika Silina, CFO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 PROMISSORY NOTE
 

 	 	
	 Principal Amount: USD$75,000
	 February 14, 2017

 

 

 FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Perla Capital Inc. (the “Lender”) the sum of $75,000 lawful money of United States (the “Principal Sum”) together with interest on the Principal Sum from February 14, 2017 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
 

 For the purposes of this promissory note, Interest Rate means six (6) per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
 

 The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.
 

 The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note
 

 BORROWER
 Cell MedX Corp.
 

 Per:
 

 

 /s/ Yanika Silina
 Yanika Silina, CFOex-10.52

 EXHIBIT 10.52
 

 

 

 LOAN AGREEMENT
 March 8, 2017
 

 Tradex Capital Corp. (the “Lender”) of 1177 W. Hastings Street, Suite 1920, Vancouver, BC V6E 2K3, advanced CAD$30,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706.  The Lender advanced the funds on March 8, 2017.
 

 The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from March 8, 2017.  The Borrower is liable for repayment for the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.
 

 The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
 

 	 	 	
	 LENDER
	  
	 BORROWER

	 Tradex Capital Corp.
	  
	 Cell MedX Corp.

	  
	  
	  

	 Per:
	  
	 Per:

	  
	  
	  

	  
	  
	  

	 /s/ William Friesen
	  
	 /s/ Yanika Silina

	 William Friesen
	  
	 Yanika Silina, CFO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 PROMISSORY NOTE
 

 	 	
	 Principal Amount: CAD$30,000
	 March 8, 2017

 

 

 FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Tradex Capital Corp. (the “Lender”) the sum of $30,000 lawful money of Canada (the “Principal Sum”) together with interest on the Principal Sum from March 8, 2017 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
 

 For the purposes of this promissory note, Interest Rate means 6 per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
 

 The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.
 

 The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note.
 

 BORROWER
 Cell MedX Corp.
 

 Per:
 

 

 /s/ Yanika Silina
 Yanika Silina, CFOex-10.53

 EXHIBIT 10.53
 

 

 

 LOAN AGREEMENT
 April 18, 2017
 

 Perla Capital Inc. (the “Lender”) of Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Marshall Islands MH96960, advanced USD$150,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706.  The Lender advanced the funds on April 18, 2017.
 

 The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) from April 18, 2017.  The Borrower is liable for repayment of the Principal Sum and accrued Interest and any costs that the Lender incurs in trying to collect the Principal Sum and the Interest.
 

 The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
 

 	 	 	
	 LENDER
	  
	 BORROWER

	 Perla Capital Inc.
	  
	 Cell MedX Corp.

	  
	  
	  

	 Per:
	  
	 Per:

	  
	  
	  

	  
	  
	  

	 /s/ Bernadette Caspillan
	  
	 /s/ Yanika Silina

	 Bernadette Caspillan
	  
	 Yanika Silina, CFO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 PROMISSORY NOTE
 

 	 	
	 Principal Amount: USD$150,000
	 April 18, 2017

 

 

 FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Perla Capital Inc. (the “Lender”) the sum of $150,000 lawful money of United States (the “Principal Sum”) together with interest on the Principal Sum from April 18, 2017 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
 

 For the purposes of this promissory note, Interest Rate means six (6) per cent per year.  Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
 

 The Borrower may repay the Principal Sum and the Interest in whole or in part at any time.
 

 The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note
 

 BORROWER
 Cell MedX Corp.
 

 Per:
 

 

 /s/ Yanika Silina
 Yanika Silina, CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]